ITM Radiopharma
Development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment.
Launch date
Employees
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Feb 2022.)
Company register number HRB 154944 (München)
Garching bei München Bavaria (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 15.6m | 23.6m | 30.4m | 43.5m | 48.3m | 79.7m | 208m |
| % growth | - | 51 % | 29 % | 43 % | 11 % | 65 % | - |
| EBITDA | (2.9m) | (3.3m) | (12.8m) | (17.0m) | (35.9m) | - | - |
| % EBITDA margin | (18 %) | (14 %) | (42 %) | (39 %) | (74 %) | - | - |
| Profit | (3.8m) | (12.4m) | (18.9m) | (23.7m) | (49.5m) | - | - |
| % profit margin | (25 %) | (53 %) | (62 %) | (55 %) | (103 %) | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€20.0m | Late VC | ||
* | €40.0m | Debt | |
* | $108m | Convertible | |
€25.0m | Late VC | ||
* | €255m | Growth Equity VC | |
* | €188m | Growth Equity VC | |
| Total Funding | €586m | ||